ENDOMETRIAL NEOPLASMS
Clinical trials for ENDOMETRIAL NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new ENDOMETRIAL NEOPLASMS trials appear
Sign up with your email to follow new studies for ENDOMETRIAL NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy shows promise for Tough-to-Treat endometrial cancer
Disease control CompletedThis study tested whether a combination of two drugs, pembrolizumab and lenvatinib, works better than standard chemotherapy for women with advanced or recurrent endometrial cancer. About 842 women with stage III, IV, or recurrent disease took part. The goal was to see if the comb…
Matched conditions: ENDOMETRIAL NEOPLASMS
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 18, 2026 11:46 UTC
-
New combo therapy shows promise against tough uterine cancer
Disease control CompletedThis study tested a combination of two drugs, pembrolizumab and lenvatinib, against standard chemotherapy for women with advanced or recurrent endometrial cancer. The goal was to see if the combo could slow cancer growth or improve survival better than chemo. The trial enrolled 1…
Matched conditions: ENDOMETRIAL NEOPLASMS
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 15, 2026 19:02 UTC
-
New combo therapy shows promise for advanced uterine cancer
Disease control CompletedThis study tested a combination of two drugs, lenvatinib and pembrolizumab, against standard chemotherapy in 827 people with advanced endometrial cancer that had worsened after initial treatment. The goal was to see if the combo could delay cancer growth and extend life. Results …
Matched conditions: ENDOMETRIAL NEOPLASMS
Phase: PHASE3 • Sponsor: Eisai Inc. • Aim: Disease control
Last updated Jun 09, 2026 12:06 UTC
-
New EHR tool aims to boost heart care for cancer survivors
Knowledge-focused CompletedThis study tested a computer tool (AH-HA) that helps doctors check heart health during routine follow-up visits for cancer survivors. About 645 survivors of breast, prostate, colorectal, endometrial, or lymphoma cancers took part across 12 clinics. The goal was to see if the tool…
Matched conditions: ENDOMETRIAL NEOPLASMS
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jun 23, 2026 11:56 UTC
-
New dye technique may improve lymph node detection in uterine cancer surgery
Knowledge-focused CompletedThis study tested whether a modified dye injection method, where surgeons watch the dye travel through lymph channels in real time, works better than the standard method for finding sentinel lymph nodes in women with early-stage endometrial cancer. Eighty patients having robotic …
Matched conditions: ENDOMETRIAL NEOPLASMS
Phase: NA • Sponsor: Bakirkoy Dr. Sadi Konuk Research and Training Hospital • Aim: Knowledge-focused
Last updated Jun 22, 2026 12:07 UTC
-
Smaller radiation margins may reduce side effects in uterine cancer treatment
Knowledge-focused CompletedThis study looked at how much extra tissue around a tumor needs to be treated with radiation after surgery for endometrial or cervical cancer. Using a special technique called online adaptive radiotherapy, doctors adjusted the radiation plan each day to see if they could safely u…
Matched conditions: ENDOMETRIAL NEOPLASMS
Phase: PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Knowledge-focused
Last updated Jun 22, 2026 12:05 UTC